| scholarly article | Q13442814 |
| P50 | author | Hugh A Sampson | Q65559603 |
| Stephen J. Galli | Q87756591 | ||
| Wyatt W Decker | Q88007221 | ||
| Dean D. Metcalfe | Q90856971 | ||
| Allen D Harlor | Q117222311 | ||
| Carlos A. Camargo | Q59765406 | ||
| P2093 | author name string | Jerrold H Levy | |
| Rebecca S Gruchalla | |||
| Lanny J Rosenwasser | |||
| Susan M Pollart | |||
| Joseph P Wood | |||
| S Allan Bock | |||
| Allen P Kaplan | |||
| Anne Muñoz-Furlong | |||
| F Estelle Simons | |||
| David L Hepner | |||
| Phillip L Lieberman | |||
| Lawrence M Lewis | |||
| Badrul A Chowdhury | |||
| Allen D Harlor | |||
| Robert Bass | |||
| Terence J Furlong | |||
| Richard S Pumphrey | |||
| Marilyn Howarth | |||
| Cara Schmitt | |||
| David B Golden | |||
| Ramon Murphy | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anaphylaxis | Q168800 |
| anaphylactic shock | Q15965523 | ||
| P304 | page(s) | 584-591 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Symposium on the definition and management of anaphylaxis: summary report. | |
| P478 | volume | 115 |
| Q37231362 | A Multicenter Retrospective Case Study of Anaphylaxis Triggers by Age in Korean Children. |
| Q35603477 | A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy |
| Q44307339 | A survey study of index food-related allergic reactions and anaphylaxis management |
| Q35809550 | Acute and preventive management of anaphylaxis in German primary school and kindergarten children |
| Q24241174 | Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock |
| Q24243567 | Adrenaline for the treatment of anaphylaxis with and without shock |
| Q45342766 | Alpha-adrenoceptor antagonists and chemical sympathectomy exacerbate anaphylaxis-induced hypotension, but not portal hypertension, in anesthetized rats |
| Q24317225 | An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions |
| Q58745878 | Anaphylaxis |
| Q59267859 | Anaphylaxis |
| Q45190779 | Anaphylaxis admissions to UK critical care units between 2005 and 2009. |
| Q33726751 | Anaphylaxis during anaesthesia: Indian scenario |
| Q35087159 | Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). |
| Q37649370 | Anaphylaxis in Schools: Results of the EPIPEN4SCHOOLS Survey Combined Analysis |
| Q41973648 | Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions |
| Q38121593 | Anaphylaxis in dogs and cats |
| Q55374006 | Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers. |
| Q34420331 | Anaphylaxis treatment: current barriers to adrenaline auto-injector use. |
| Q24606957 | Anaphylaxis: a history with emphasis on food allergy |
| Q80068216 | Anaphylaxis: an overview from one referral clinic |
| Q31109981 | Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data |
| Q34423618 | Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. |
| Q83275525 | Anaphylaxis: persistent enigma |
| Q81301063 | Anaphylaxis: trying to bring meaning to uncertainty |
| Q38858992 | Antiallergic effects of peiminine through the regulation of inflammatory mediators in HMC-1 cells |
| Q48503939 | Are Registration of Disease Codes for Adult Anaphylaxis Accurate in the Emergency Department? |
| Q38796955 | Atomic force microscopy study of ionomycin-induced degranulation in RBL-2H3 cells |
| Q46508414 | Availability of the epinephrine autoinjector at school in children with peanut allergy |
| Q30441575 | Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose |
| Q37199236 | Clinical immunology review series: an approach to the patient with anaphylaxis. |
| Q37820336 | Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs |
| Q36080035 | Comparisons of serum total IgE, IgG, and IgG1 levels in patients with and without echinococcosis-induced anaphylactic shock |
| Q30582096 | DOCK5 functions as a key signaling adaptor that links FcεRI signals to microtubule dynamics during mast cell degranulation |
| Q35186807 | Demographic and clinical characteristics of patients with anaphylactic shock after surgery for cystic echinococcosis |
| Q33372977 | Development of a food allergy education resource for primary care physicians |
| Q88427564 | Diagnostic role of serum tryptase in anaphylactic deaths in forensic medicine: a systematic review and meta-analysis |
| Q36752204 | Emergencies in allergy practice. |
| Q36682152 | Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group |
| Q59218206 | Epinephrine: The Drug of Choice for Anaphylaxis--A Statement of the World Allergy Organization |
| Q36882535 | Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization |
| Q36445108 | Evaluation of IgE Antibodies to Omalizumab (Xolair®) and Their Potential Correlation to Anaphylaxis |
| Q33166156 | Exercise-induced anaphylaxis and antileukotriene montelukast |
| Q37606593 | Factors Associated with Echinococcosis-Induced Perioperative Anaphylactic Shock |
| Q64109676 | Food Allergen Sensitisation Patterns in Omani Patients with Allergic Manifestations |
| Q21245392 | Food allergy |
| Q45978834 | Food allergy and anaphylaxis in infants and preschool-age children. |
| Q36873165 | Food-dependent exercise-induced anaphylaxis in childhood |
| Q30458593 | Food-induced anaphylaxis. |
| Q37585269 | Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity |
| Q87134095 | Glucocorticoids for the treatment of anaphylaxis |
| Q24200443 | Glucocorticoids for the treatment of anaphylaxis |
| Q24236588 | Glucocorticoids for the treatment of anaphylaxis |
| Q24242546 | Glucocorticoids for the treatment of anaphylaxis |
| Q28300001 | Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel |
| Q26781692 | Guidelines for the use and interpretation of diagnostic methods in adult food allergy |
| Q24245913 | H1-antihistamines for the treatment of anaphylaxis with and without shock |
| Q24246206 | H1-antihistamines for the treatment of anaphylaxis with and without shock |
| Q33290329 | H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. |
| Q58745882 | IgE-mediated food allergy |
| Q38085051 | Immunopathogenesis of allergic disorders: current concepts |
| Q41538802 | Incidence of anaphylactic reactions after propofol administration in dogs |
| Q51353311 | Incidence of anaphylaxis in the city of Alcorcon (Spain): a population-based study. |
| Q28478563 | Justified concern or exaggerated fear: the risk of anaphylaxis in percutaneous treatment of cystic echinococcosis-a systematic literature review |
| Q93563722 | Letter to the editor: Diagnostic procedures and case related information in ICM-induced hypersensitivity |
| Q30687509 | MRI reveals edema in larynx (but not in brain) during anaphylactic hypotension in anesthetized rats |
| Q37457346 | Mechanisms of mast cell signaling in anaphylaxis |
| Q93109315 | Missed Registration of Disease Codes for Pediatric Anaphylaxis at the Emergency Department |
| Q35530004 | NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population |
| Q53237542 | National study of US emergency department visits for acute allergic reactions, 1993 to 2004. |
| Q33864947 | Navigating the updated anaphylaxis parameters |
| Q34631769 | Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment |
| Q30234969 | Outpatient Emergencies: Anaphylaxis |
| Q33999649 | Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). |
| Q37397221 | Pediatric anaphylaxis management in the prehospital setting. |
| Q44343771 | Penicillin sensitivity among hospital nurses without a history of penicillin allergy |
| Q88124330 | Perioperative anaphylaxis |
| Q58571501 | Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles |
| Q34129668 | Post-mortem diagnosis of anaphylaxis: A difficult task in forensic medicine |
| Q33783268 | Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis |
| Q37167148 | Prevalence of sensitization to food allergens and challenge proven food allergy in patients visiting allergy centers in Rawalpindi and Islamabad, Pakistan |
| Q40423488 | Rate of recurrent anaphylaxis and associated risk factors among Olmsted County, Minnesota, residents: A population-based study |
| Q91675702 | Recruiting CD33 on mast cells to inhibit IgE-mediated mast cell-dependent anaphylaxis |
| Q41982950 | Research to practice: developing an integrated anaphylaxis education curriculum for school nurses |
| Q48252549 | Risk factors for developing food-induced bronchospasm during oral food challenge |
| Q36665226 | Risk of anaphylaxis after vaccination in children and adults |
| Q36865022 | SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department |
| Q37071176 | SG-HQ2 inhibits mast cell-mediated allergic inflammation through suppression of histamine release and pro-inflammatory cytokines |
| Q28469039 | Serious shortcomings in the management of children with anaphylaxis in Scottish schools |
| Q92576834 | Suspected anaphylactic shock associated with administration of tranexamic acid in a dog |
| Q27025706 | Systematic review of outcome measures in trials of pediatric anaphylaxis treatment |
| Q46459696 | The comparative safety of various intravenous iron preparations in chronic kidney disease patients |
| Q36613696 | The development of allergic inflammation |
| Q82980917 | The diagnosis and management of egg allergy |
| Q37247220 | The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. |
| Q36284065 | The need for routine bleomycin test dosing in the 21st century |
| Q47575091 | The vascular endothelial specific IL-4 receptor alpha-ABL1 kinase signaling axis regulates the severity of IgE-mediated anaphylactic reactions. |
| Q40667063 | Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A population-based study. |
| Q37195584 | Understanding the mechanisms of anaphylaxis |
| Q31004107 | Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). |
| Q28282226 | World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines |
| Q34319703 | World allergy organization guidelines for the assessment and management of anaphylaxis |
| Q84919749 | [Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria] |
| Q84582191 | [Pulmonary allergic reactions] |
| Q47142914 | β₂-Adrenoceptor Blockade Deteriorates Systemic Anaphylaxis by Enhancing Hyperpermeability in Anesthetized Mice |
Search more.